Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres

被引:211
作者
Blanco, MD [1 ]
Alonso, MJ [1 ]
机构
[1] UNIV SANTIAGO DE COMPOSTELA,FAC PHARM,DEPT PHARMACOL PHARM & PHARMACEUT TECHNOL,SANTIAGO COMPOSTE 15706,SPAIN
关键词
biodegradable nanospheres; poly(lactide-co-glycolide); multiple emulsion; protein delivery; protein stability;
D O I
10.1016/S0939-6411(97)00056-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The goal of this work is to develop poly(lactide-co-glycolide) (PLGA) nanospheres designed to deliver proteins for extended periods of time. To accomplish this goal a water-in-oil-in-water emulsion technique was conveniently modified. A study was performed to evaluate how the solvent elimination procedure, the copolymer type (different molecular weight and containing either free or esterified carboxyls) and the surfactant Poloxamer 188 affected the properties of the nanoparticles. The size of the nanospheres become larger (from 300 to 600 nm) by increasing the copolymer molecular weight and by the incorporation of Poloxamer 188. The protein loading efficiency varied from 40 to 90%, reaching the maximum Values for the formulations made of PLGA with free carboxyls. However, the co-encapsulation of Poloxamer 188 reduced the protein loading. The in vitro protein release rate, was fairly constant after an initial burst release. The release rate was significantly reduced for the copolymer with terminal free carboxyls but was enhanced by the incorporation of Poloxamer 188 in the nanoparticles. No significant aggregation or fragmentation of the encapsulated protein was observed after incubation for 1 month. Consequently, these nanoparticles can be proposed as new controlled release protein delivery systems. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 27 条
[1]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[2]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[3]   DETERMINANTS OF RELEASE RATE OF TETANUS VACCINE FROM POLYESTER MICROSPHERES [J].
ALONSO, MJ ;
COHEN, S ;
PARK, TG ;
GUPTA, RK ;
SIBER, GR ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :945-953
[4]  
Alonso MJ, 1996, DRUGS PHARM SCI, P203
[5]  
ALONSO MJ, 1996, P INT S CONTROL RELE, V23, P831
[6]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[7]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214
[8]  
ERMAK TH, 1995, CELL TISSUE RES, V279, P433, DOI 10.1007/BF00318501
[9]   PARAMETERS AFFECTING THE IMMUNOGENICITY OF MICROENCAPSULATED TETANUS TOXOID [J].
ESPARZA, I ;
KISSEL, T .
VACCINE, 1992, 10 (10) :714-720
[10]   QUALITY IMPROVEMENT OF SPRAY-DRIED, PROTEIN-LOADED D,L-PLA MICROSPHERES BY APPROPRIATE POLYMER-SOLVENT SELECTION [J].
GANDER, B ;
WEHRLI, E ;
ALDER, R ;
MERKLE, HP .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (01) :83-97